Michael Rabinowitz
CIK 1767090 · View on SEC EDGAR ↗
First SEC filing: Jan. 5, 2022 · Latest: Jan. 5, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2022 | ORMP | A | 32,000 | — | — | 32,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Jan. 3, 2022 | ORMP | A | 19,000 | — | — | 109,468 Direct | +21.00% | Acquired | (price as of 2026-08-19) |
| Dec. 28, 2021 | ORMP | F | 9,532 | $12.98 | $123,725 | 90,468 Direct | -9.53% | Disposed | -62.8% (price as of 2026-08-19) |
| Aug. 4, 2021 | ORMP | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 4, 2021 | ORMP | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 3, 2022 | ORMP | Stock Option (right to buy) | Common Stock (32,000) | $13.89 | Jan. 3, 2032 | 32,000 | Acquired |
| Aug. 4, 2021 | ORMP | Stock Option (right to buy) | Common Stock (100,000) | $15.10 | Aug. 4, 2031 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).